OptiCept Technologies（725）株式概要オプティセプト・テクノロジーズ社（OptiCept Technologies AB）は、様々な生物学的プロセスを最適化するために電気パルスを制御・応用する技術をスウェーデン国内外で開発している。 詳細725 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長5/6過去の実績0/6財務の健全性2/6配当金0/6報酬当社が推定した公正価値より88.2%で取引されている 収益は年間105.42%増加すると予測されています リスク分析German市場と比較して、過去 3 か月間の株価の変動が非常に大きいキャッシュランウェイが1年未満である 意味のある収益がありません ( SEK37M )意味のある時価総額がありません ( €12M )すべてのリスクチェックを見る725 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.1447.5% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-100m118m2016201920222025202620282031Revenue SEK 118.3mEarnings SEK 11.0mAdvancedSet Fair ValueView all narrativesOptiCept Technologies AB (publ) 競合他社SCHUMAGSymbol: DB:SCMMarket cap: €11.2mPittler MaschinenfabrikSymbol: DB:PITMarket cap: €4.0mBigRepSymbol: DB:B1GRMarket cap: €3.5mDATRONSymbol: XTRA:DARMarket cap: €38.9m価格と性能株価の高値、安値、推移の概要OptiCept Technologies過去の株価現在の株価SEK 0.1452週高値SEK 0.5252週安値SEK 0.13ベータ-0.381ヶ月の変化-1.44%3ヶ月変化5.73%1年変化-62.21%3年間の変化-79.55%5年間の変化-97.28%IPOからの変化-97.24%最新ニュースBreakeven Date Change • May 20Forecast to breakeven in 2028The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests losses will reduce by 85% per year to 2027. The company is expected to make a profit of kr15.0m in 2028. Average annual earnings growth of 105% is required to achieve expected profit on schedule.Board Change • May 20High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. Chairman of the Board Ulf Hagman is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Mar 27+ 3 more updatesOptiCept Technologies AB (publ) to Report Q2, 2026 Results on Aug 28, 2026OptiCept Technologies AB (publ) announced that they will report Q2, 2026 results on Aug 28, 2026お知らせ • Dec 19Opticept Technologies AB (Publ) Appoints Mikael Carleson and Jörgen Durban as Board MembersOptiCept Technologies AB (publ) at its EGM held on December 18, 2025 appointed Mikael Carleson and Jörgen Durban were elected as new Board members.お知らせ • Nov 22+ 1 more updateOptiCept Technologies AB (publ) to Report Fiscal Year 2025 Final Results on Mar 27, 2026OptiCept Technologies AB (publ) announced that they will report fiscal year 2025 final results on Mar 27, 2026お知らせ • Oct 22OptiCept Technologies AB (publ), Annual General Meeting, May 21, 2026OptiCept Technologies AB (publ), Annual General Meeting, May 21, 2026.最新情報をもっと見るRecent updatesBreakeven Date Change • May 20Forecast to breakeven in 2028The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests losses will reduce by 85% per year to 2027. The company is expected to make a profit of kr15.0m in 2028. Average annual earnings growth of 105% is required to achieve expected profit on schedule.Board Change • May 20High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. Chairman of the Board Ulf Hagman is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Mar 27+ 3 more updatesOptiCept Technologies AB (publ) to Report Q2, 2026 Results on Aug 28, 2026OptiCept Technologies AB (publ) announced that they will report Q2, 2026 results on Aug 28, 2026お知らせ • Dec 19Opticept Technologies AB (Publ) Appoints Mikael Carleson and Jörgen Durban as Board MembersOptiCept Technologies AB (publ) at its EGM held on December 18, 2025 appointed Mikael Carleson and Jörgen Durban were elected as new Board members.お知らせ • Nov 22+ 1 more updateOptiCept Technologies AB (publ) to Report Fiscal Year 2025 Final Results on Mar 27, 2026OptiCept Technologies AB (publ) announced that they will report fiscal year 2025 final results on Mar 27, 2026お知らせ • Oct 22OptiCept Technologies AB (publ), Annual General Meeting, May 21, 2026OptiCept Technologies AB (publ), Annual General Meeting, May 21, 2026.お知らせ • May 29+ 1 more updateOptiCept Technologies AB (publ) to Report Q3, 2025 Results on Nov 27, 2025OptiCept Technologies AB (publ) announced that they will report Q3, 2025 results on Nov 27, 2025お知らせ • Nov 29OptiCept Technologies AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 80.463125 million.OptiCept Technologies AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 80.463125 million. Security Name: Shares Security Type: Common Stock Securities Offered: 16,092,625 Price\Range: SEK 5 Transaction Features: Rights Offeringお知らせ • Nov 27OptiCept Technologies AB (publ) Expands Project with Dole in ThailandOptiCept has successfully completed its project with Dole in Thailand, which was announced in the spring of 2024. Following positive results, Dole has decided to extend and expand the collaboration to further explore the potential of OptiCept's technology platforms. The focus is now on optimizing the drying process for pineapples. During the initial 14-day pilot period, OptiCept achieved the project goals. The treatment resulted in improved texture in pineapple products, making them more appealing to new markets with high-quality standards. At the same time, an evaluation of the drying process showed significantly increased efficiency through reduced drying times. As a result, Dole wants to conduct further tests to fully map the commercial benefits of PEF (Pulsed Electric Field) technology in the pineapple drying process. The project is therefore entering a commercial phase. Thailand is a globally significant producer of pineapples, with an annual production of approximately 1.2 million tons, placing the country among the top five producers worldwide. Asia is also the world's largest region in terms of both production and consumption of pineapples, making the Thai market a strategic priority for OptiCept.Buy Or Sell Opportunity • Nov 11Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 27% to €0.41. The fair value is estimated to be €0.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 749% in 2 years. Earnings are forecast to grow by 93% in the next 2 years.Breakeven Date Change • Oct 21Forecast to breakeven in 2026The 2 analysts covering OptiCept Technologies expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 51% per year to 2025. The company is expected to make a profit of kr1.85m in 2026. Average annual earnings growth of 87% is required to achieve expected profit on schedule.Reported Earnings • Oct 19Third quarter 2024 earnings released: kr0.28 loss per share (vs kr0.67 loss in 3Q 2023)Third quarter 2024 results: kr0.28 loss per share (improved from kr0.67 loss in 3Q 2023). Net loss: kr13.1m (loss narrowed 37% from 3Q 2023). Revenue is forecast to grow 49% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Machinery industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.New Risk • Oct 18New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: kr67m Forecast net loss in 3 years: kr622k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr67m). Currently unprofitable and not forecast to become profitable over next 3 years (kr622k net loss in 3 years). Share price has been volatile over the past 3 months (10% average weekly change). Revenue is less than US$5m (kr15m revenue, or US$1.4m). Market cap is less than US$100m (€34.0m market cap, or US$36.9m).お知らせ • Oct 11OptiCept Technologies AB (publ), Annual General Meeting, May 22, 2025OptiCept Technologies AB (publ), Annual General Meeting, May 22, 2025.New Risk • Oct 09New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr67m). Revenue is less than US$5m (kr15m revenue, or US$1.4m). Market cap is less than US$100m (€27.6m market cap, or US$30.3m).お知らせ • Oct 03Opticept Technologies AB (publ) Announces Chief Financial Officer ChangesOptiCept Technologies AB (publ) announced that OptiCept's Chief Financial Officer, Despina Georgiadou Hedin, has decided to step down from her role. Henrik Nettersand will be the new CFO. Despina Georgiadou Hedin, who has been CFO at OptiCept Technologies since 2023, will leave her position no later than April 2, 2025. Henrik Nettersand, currently CFO at S:t Eriks AB, will succeed her. Henrik Nettersand most recently served as CFO at S:t Eriks AB and will assume his new role no later than April 2, 2025. Previously, he was CFO at Besikta Bilprovning for five years and held several leadership roles during his eleven years at John Bean Technologies AB, including as Head of Finance. He began his career as an auditor at KPMG and holds a Master of Science in Economics and Business Administration from Lund University, with a specialization in finance. Henrik has many years of experience in financial leadership roles, both at the company and group levels, and has extensive global experience. His long experience working with multinational companies in growth, both inside and outside Sweden, and with companies delivering complex food technology globally, has given him the expertise and business focus the company need in its global expansion.New Risk • Sep 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr67m). Revenue is less than US$5m (kr15m revenue, or US$1.4m). Market cap is less than US$100m (€23.2m market cap, or US$25.8m).Reported Earnings • Aug 30Second quarter 2024 earnings released: kr0.23 loss per share (vs kr0.57 loss in 2Q 2023)Second quarter 2024 results: kr0.23 loss per share (improved from kr0.57 loss in 2Q 2023). Net loss: kr10.3m (loss narrowed 39% from 2Q 2023). Revenue is forecast to grow 48% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Machinery industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 58% per year, which means it is significantly lagging earnings.Buy Or Sell Opportunity • Jul 17Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 153% to €0.59. The fair value is estimated to be €0.48, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 1,205% in 2 years. Earnings are forecast to grow by 81% in the next 2 years.お知らせ • Jul 02OptiCept Technologies AB Submits Patent Application and Strengthens Its IP-Portfolio for Vacuum Impregnation Focused on CuttingsOptiCept Technologies AB announced that the company has submitted a patent application to the Swedish Patent and Registration Office (PRV). The patent application includes strengthened and expanded patent protection for the company's vacuum impregnation technology, OptiBoost. OptiCept brings the vacuum infusion platform to the next level by specifying the successful treatment conditions for its plant technology platform, OptiBoost. The patent application encompasses the detailed method of treating the plant material such as cuttings leading to improved rooting. Successes with tests on cuttings have prompted the submission of the patent application. The company learns and develops with every new test. The method that OptiCept uses is mastered, and the knowledge of how to control and implement it is becoming stronger and stronger with new activities and a growing portfolio of tested species.The patent application expounds the exact conditions for applying the vacuum infusion process to achieve the most optimal treatment for plants. The treatment must be mild and well-controlled to minimize the stress applied to the plant tissue, which is ensured by the innovative way of designing the vacuum curve. The patent also describes the correct treatment criteria by controlling the percentage of air removed from the tissue and percentage of liquid incorporated into the tissue by specifying the surface impregnation parameters.Buy Or Sell Opportunity • Jul 01Now 3.4% overvalued after recent price riseOver the last 90 days, the stock has risen 83% to €0.46. The fair value is estimated to be €0.44, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 1,205% in 2 years. Earnings are forecast to grow by 81% in the next 2 years.Buy Or Sell Opportunity • Jun 25Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 95% to €0.50. The fair value is estimated to be €0.41, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 1,205% in 2 years. Earnings are forecast to grow by 81% in the next 2 years.Breakeven Date Change • Jun 05Forecast to breakeven in 2026The 2 analysts covering OptiCept Technologies expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 60% per year to 2025. The company is expected to make a profit of kr6.00m in 2026. Average annual earnings growth of 82% is required to achieve expected profit on schedule.Reported Earnings • Jun 04First quarter 2024 earnings released: kr0.35 loss per share (vs kr0.71 loss in 1Q 2023)First quarter 2024 results: kr0.35 loss per share (improved from kr0.71 loss in 1Q 2023). Net loss: kr14.7m (loss narrowed 30% from 1Q 2023). Revenue is forecast to grow 44% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Machinery industry in Germany. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 58% per year, which means it is performing significantly worse than earnings.Board Change • May 30Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Anders Hattmark was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.お知らせ • Apr 12OptiCept Technologies AB Files Patent Application for Combined PEF and VI Treatment of Fruit and Vegetable ProductsOptiCept Technologies AB announced that the company has submitted a new patent application to the Swedish Intellectual Property Office (PRV). The patent application includes a new application area for the company's technologyplatforms CEPT (Controlled Environment PEF treatment) and VI (Vacuum infusion) in fruit and vegetable processing. Success with tests on pineapple chunks has prompted the filing of the patent application. OptiCept has developed a new application area for the company's technology platforms. The patent application includes a Pulsed Electric Field (PEF) step followed by a vacuum injection step, or the steps separately for softening fruit or vegetable products (pieces of fruit or vegetables), where the fruit or vegetable products are impregnated with fruit or vegetable juice to improve product color and texture. This new technology can naturally improve the organoleptic properties of products to be even more appreciated by consumers due to improved texture, consistency, and color. It also creates the conditions to produce completely new products. Success with tests on pineapple chunks has prompted the filing of the patent application.Reported Earnings • Feb 28Full year 2023 earnings released: kr2.48 loss per share (vs kr5.03 loss in FY 2022)Full year 2023 results: kr2.48 loss per share (improved from kr5.03 loss in FY 2022). Net loss: kr80.4m (loss narrowed 20% from FY 2022). Revenue is forecast to grow 41% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the Machinery industry in Germany.お知らせ • Feb 27OptiCept Technologies AB (publ), Annual General Meeting, May 24, 2024OptiCept Technologies AB (publ), Annual General Meeting, May 24, 2024.お知らせ • Dec 22OptiCept Technologies AB (publ) Receives First Partial Results from the Pilot Project to Improve the Staining of Cuttings in ChinaOptiCept Technologies AB (publ) announced that it has received the first partial results from the pilot project to improve the rooting of cuttings in China, which initially focuses on Acacia. The root of Acacia cuttings improved by 12-33% depending on the type of Acacia treated. In May 2023, OptiCept Technologies entered an agreement with Guangxi Shichen Group ("GSG"), in collaboration with the Chinese state research institute Guangxi Academy of Forestry, to evaluate the OptiBoost technology on several different types of cuttings to improve its rooting. Acacia cuttings treated with the patented vacuum impregnation technology show an average improved rooting of 12-33% after 45 days, with the final assessment made after 90 days. Results from the evaluation of Camelia will be available in 2024 when tests for Eucalyptus also will be carried out. Acacia is a large genus with many species. Cultivation of Acacia is particularly common in China, Southeast Asia, South America, Africa, and in Australia, where Acacia forest is the second most common forest type after Eucalyptus forest. Acacia is one of the most cultivated trees in the southern hemisphere and is a fast-growing species that can grow in harsh conditions that other species cannot, which can quickly generate yields.Reported Earnings • Nov 30Third quarter 2023 earnings released: kr0.67 loss per share (vs kr1.09 loss in 3Q 2022)Third quarter 2023 results: kr0.67 loss per share (improved from kr1.09 loss in 3Q 2022). Net loss: kr20.7m (loss narrowed 4.4% from 3Q 2022). Revenue is forecast to grow 85% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Machinery industry in Germany.お知らせ • Nov 30+ 2 more updatesOptiCept Technologies AB (publ) to Report Fiscal Year 2023 Results on Feb 27, 2024OptiCept Technologies AB (publ) announced that they will report fiscal year 2023 results on Feb 27, 2024New Risk • Oct 24New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.39m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Revenue is less than US$1m (kr10m revenue, or US$925k). Market cap is less than US$10m (€9.39m market cap, or US$9.95m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr104m). Currently unprofitable and not forecast to become profitable over next 2 years (kr14m net loss in 2 years).お知らせ • Oct 22OptiCept Technologies AB (publ) Announces CFO ChangesOptiCept Technologies AB (publ) recruited Déspina Georgiadou Hedin as the company's new CFO. Déspina most recently comes from Ascelia Pharma AB (publ), where she held the position of CFO. She will take up her position no later than 1 November 2023. Déspina Georgiadou Hedin now replaces Tomas Andersson, who acted as interim CFO since April 2023 while a permanent recruitment was carried out. She has extensive experience in leading positions in finance and the role of CFO for both listed and unlisted companies. Most recently, she was the CFO at Ascelia Pharma AB and before that, she was, among other things, CFO and HR manager at Bioglan AB, as well as Chief Accountant and Senior Financial Specialist at Sol Voltaics AB. Déspina has a bachelor's degree in economics from Linnaeus University, Växjö/Kalmar.Reported Earnings • Aug 30Second quarter 2023 earnings released: kr0.57 loss per share (vs kr1.10 loss in 2Q 2022)Second quarter 2023 results: kr0.57 loss per share (improved from kr1.10 loss in 2Q 2022). Net loss: kr17.1m (loss narrowed 22% from 2Q 2022). Revenue is forecast to grow 71% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Machinery industry in Germany.お知らせ • Feb 07OptiCept Technologies AB (publ), Annual General Meeting, Mar 08, 2023OptiCept Technologies AB (publ), Annual General Meeting, Mar 08, 2023.Breakeven Date Change • Nov 16Forecast breakeven date pushed back to 2024The analyst covering OptiCept Technologies previously expected the company to break even in 2022. New forecast suggests losses will reduce by 35% per year to 2023. The company is expected to make a profit of kr2.00m in 2024. Average annual earnings growth of 87% is required to achieve expected profit on schedule.Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). Director Elisabeth Yllfors was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Breakeven Date Change • Nov 08Forecast breakeven date pushed back to 2024The analyst covering OptiCept Technologies previously expected the company to break even in 2022. New forecast suggests losses will reduce by 35% per year to 2023. The company is expected to make a profit of kr2.00m in 2024. Average annual earnings growth of 87% is required to achieve expected profit on schedule.お知らせ • Oct 01Thomas Lundqvist acquired additional minority stakes in OptiCept Technologies AB (publ) (OM:OPTI).Thomas Lundqvist acquired additional minority stakes in OptiCept Technologies AB (publ) (OM:OPTI) on September 29, 2022. Thomas Lundqvist ill acquire 5300 shares at a price of SEK 28.28. Thomas Lundqvist completed the acquisition of additional minority stakes in OptiCept Technologies AB (publ) (OM:OPTI) on September 29, 2022.お知らせ • May 17Opticept Technologies AB (publ) Announces CEO ChangesOptiCept Technologies' CEO Johan Möllerström has chosen to resign as CEO from the Annual General Meeting on May 25, 2022. The new CEO will be Thomas Lundqvist, who is currently part of the management team as Head of Sales. Johan Möllerström has been CEO of ArcAroma and now OptiCept for 5.5 years and over the years has changed the companies' focus from biogas to food, from freezing processes to cut flowers, and from innovation to commercial success.Reported Earnings • May 09First quarter 2022 earnings released: kr0.74 loss per share (vs kr0.47 loss in 1Q 2021)First quarter 2022 results: kr0.74 loss per share (down from kr0.47 loss in 1Q 2021). Net loss: kr14.8m (loss widened 162% from 1Q 2021). Over the next year, revenue is forecast to grow 4,589%, compared to a 8.9% growth forecast for the industry in Germany.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). Director Elisabeth Yllfors was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Apr 02+ 3 more updatesOptiCept Technologies AB (publ), Annual General Meeting, May 25, 2022OptiCept Technologies AB (publ), Annual General Meeting, May 25, 2022.Reported Earnings • Feb 10Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: kr2.61 loss per share (down from kr1.23 loss in FY 2020). Net loss: kr42.5m (loss widened 199% from FY 2020). Revenue missed analyst estimates by 38%. Over the next year, revenue is forecast to grow 2,568%, compared to a 10% growth forecast for the industry in Germany.Breakeven Date Change • Sep 23Forecast to breakeven in 2021The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests the company will make a profit of kr40.0m in 2021. Earnings growth of 89% is required to achieve expected profit on schedule.Reported Earnings • Feb 18Full year 2020 earnings released: kr1.03 loss per share (vs kr0.81 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: kr3.33m (down 40% from FY 2019). Net loss: kr11.9m (loss widened 43% from FY 2019).お知らせ • Feb 18OptiFreeze AB (publ) (NGM:OPTI) agreed to acquire ArcAroma AB (publ) (OM:AAA).OptiFreeze AB (publ) (NGM:OPTI) agreed to acquire ArcAroma AB (publ) (OM:AAA) on February 16, 2021. The transaction is subject to shareholders approval of ArcAroma AB (publ). The transaction is approved by the Board of ArcAroma AB (publ).株主還元725DE MachineryDE 市場7D7.4%0.2%3.2%1Y-62.2%-0.3%2.5%株主還元を見る業界別リターン: 725過去 1 年間で-0.3 % の収益を上げたGerman Machinery業界を下回りました。リターン対市場: 725は、過去 1 年間で2.5 % のリターンを上げたGerman市場を下回りました。価格変動Is 725's price volatile compared to industry and market?725 volatility725 Average Weekly Movement26.2%Machinery Industry Average Movement5.2%Market Average Movement6.1%10% most volatile stocks in DE Market13.6%10% least volatile stocks in DE Market2.7%安定した株価: 725の株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 725の 週次ボラティリティ は、過去 1 年間で18%から26%に増加しました。会社概要設立従業員CEO（最高経営責任者ウェブサイト201123Henrik Nettersandwww.opticept.seオプティセプト・テクノロジーズ社（OptiCept Technologies AB）は、様々な生物学的プロセスを最適化するために電気パルスを制御・応用する技術をスウェーデン国内外で開発している。同社は、ジュース製造機juiceCEPT、ジュース産業用アプリケーションjuiceCEPT+、エキストラバージンオリーブオイル（EVOO）製造においてオリーブペーストの前処理を行い、製品の品質を向上させ、EVOOの抽出収量を増加させるoliveCEPT、バイオマス中の標的細胞膜を処理する技術wineCEPT、乾燥時間を短縮し、風味を向上させ、最終乾燥製品の色を鮮やかにするdryCEPTなどのフードテック製品を提供している。また、切花用OptiBoostや挿し木用OptiBoostなどのプラントテック製品も提供している。同社の製品は、ビール、乳製品、花、食用油、ジュース、植物ミルク、ワインなどの用途に使用されている。同社は以前はOptiFreeze AB（publ）として知られていたが、2021年7月にOptiCept Technologies AB（publ）に社名を変更した。OptiCept Technologies AB（publ）は2011年に設立され、スウェーデンのルンドに本社を置いている。もっと見るOptiCept Technologies AB (publ) 基礎のまとめOptiCept Technologies の収益と売上を時価総額と比較するとどうか。725 基礎統計学時価総額€11.57m収益（TTM）-€8.33m売上高(TTM)€3.38m3.4xP/Sレシオ-1.4xPER（株価収益率725 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計725 損益計算書（TTM）収益SEK 36.66m売上原価SEK 24.27m売上総利益SEK 12.39mその他の費用SEK 102.88m収益-SEK 90.49m直近の収益報告Dec 31, 2025次回決算日May 29, 2026一株当たり利益（EPS）-1.40グロス・マージン33.80%純利益率-246.80%有利子負債／自己資本比率15.4%725 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 17:38終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋OptiCept Technologies AB (publ) 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Hjalmar JernstromDNB Carnegie Commissioned Research
Breakeven Date Change • May 20Forecast to breakeven in 2028The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests losses will reduce by 85% per year to 2027. The company is expected to make a profit of kr15.0m in 2028. Average annual earnings growth of 105% is required to achieve expected profit on schedule.
Board Change • May 20High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. Chairman of the Board Ulf Hagman is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Mar 27+ 3 more updatesOptiCept Technologies AB (publ) to Report Q2, 2026 Results on Aug 28, 2026OptiCept Technologies AB (publ) announced that they will report Q2, 2026 results on Aug 28, 2026
お知らせ • Dec 19Opticept Technologies AB (Publ) Appoints Mikael Carleson and Jörgen Durban as Board MembersOptiCept Technologies AB (publ) at its EGM held on December 18, 2025 appointed Mikael Carleson and Jörgen Durban were elected as new Board members.
お知らせ • Nov 22+ 1 more updateOptiCept Technologies AB (publ) to Report Fiscal Year 2025 Final Results on Mar 27, 2026OptiCept Technologies AB (publ) announced that they will report fiscal year 2025 final results on Mar 27, 2026
お知らせ • Oct 22OptiCept Technologies AB (publ), Annual General Meeting, May 21, 2026OptiCept Technologies AB (publ), Annual General Meeting, May 21, 2026.
Breakeven Date Change • May 20Forecast to breakeven in 2028The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests losses will reduce by 85% per year to 2027. The company is expected to make a profit of kr15.0m in 2028. Average annual earnings growth of 105% is required to achieve expected profit on schedule.
Board Change • May 20High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. 2 experienced directors. No highly experienced directors. Chairman of the Board Ulf Hagman is the most experienced director on the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Mar 27+ 3 more updatesOptiCept Technologies AB (publ) to Report Q2, 2026 Results on Aug 28, 2026OptiCept Technologies AB (publ) announced that they will report Q2, 2026 results on Aug 28, 2026
お知らせ • Dec 19Opticept Technologies AB (Publ) Appoints Mikael Carleson and Jörgen Durban as Board MembersOptiCept Technologies AB (publ) at its EGM held on December 18, 2025 appointed Mikael Carleson and Jörgen Durban were elected as new Board members.
お知らせ • Nov 22+ 1 more updateOptiCept Technologies AB (publ) to Report Fiscal Year 2025 Final Results on Mar 27, 2026OptiCept Technologies AB (publ) announced that they will report fiscal year 2025 final results on Mar 27, 2026
お知らせ • Oct 22OptiCept Technologies AB (publ), Annual General Meeting, May 21, 2026OptiCept Technologies AB (publ), Annual General Meeting, May 21, 2026.
お知らせ • May 29+ 1 more updateOptiCept Technologies AB (publ) to Report Q3, 2025 Results on Nov 27, 2025OptiCept Technologies AB (publ) announced that they will report Q3, 2025 results on Nov 27, 2025
お知らせ • Nov 29OptiCept Technologies AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 80.463125 million.OptiCept Technologies AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 80.463125 million. Security Name: Shares Security Type: Common Stock Securities Offered: 16,092,625 Price\Range: SEK 5 Transaction Features: Rights Offering
お知らせ • Nov 27OptiCept Technologies AB (publ) Expands Project with Dole in ThailandOptiCept has successfully completed its project with Dole in Thailand, which was announced in the spring of 2024. Following positive results, Dole has decided to extend and expand the collaboration to further explore the potential of OptiCept's technology platforms. The focus is now on optimizing the drying process for pineapples. During the initial 14-day pilot period, OptiCept achieved the project goals. The treatment resulted in improved texture in pineapple products, making them more appealing to new markets with high-quality standards. At the same time, an evaluation of the drying process showed significantly increased efficiency through reduced drying times. As a result, Dole wants to conduct further tests to fully map the commercial benefits of PEF (Pulsed Electric Field) technology in the pineapple drying process. The project is therefore entering a commercial phase. Thailand is a globally significant producer of pineapples, with an annual production of approximately 1.2 million tons, placing the country among the top five producers worldwide. Asia is also the world's largest region in terms of both production and consumption of pineapples, making the Thai market a strategic priority for OptiCept.
Buy Or Sell Opportunity • Nov 11Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 27% to €0.41. The fair value is estimated to be €0.51, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 15%. Revenue is forecast to grow by 749% in 2 years. Earnings are forecast to grow by 93% in the next 2 years.
Breakeven Date Change • Oct 21Forecast to breakeven in 2026The 2 analysts covering OptiCept Technologies expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 51% per year to 2025. The company is expected to make a profit of kr1.85m in 2026. Average annual earnings growth of 87% is required to achieve expected profit on schedule.
Reported Earnings • Oct 19Third quarter 2024 earnings released: kr0.28 loss per share (vs kr0.67 loss in 3Q 2023)Third quarter 2024 results: kr0.28 loss per share (improved from kr0.67 loss in 3Q 2023). Net loss: kr13.1m (loss narrowed 37% from 3Q 2023). Revenue is forecast to grow 49% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Machinery industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 54% per year, which means it is significantly lagging earnings.
New Risk • Oct 18New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: kr67m Forecast net loss in 3 years: kr622k This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr67m). Currently unprofitable and not forecast to become profitable over next 3 years (kr622k net loss in 3 years). Share price has been volatile over the past 3 months (10% average weekly change). Revenue is less than US$5m (kr15m revenue, or US$1.4m). Market cap is less than US$100m (€34.0m market cap, or US$36.9m).
お知らせ • Oct 11OptiCept Technologies AB (publ), Annual General Meeting, May 22, 2025OptiCept Technologies AB (publ), Annual General Meeting, May 22, 2025.
New Risk • Oct 09New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr67m). Revenue is less than US$5m (kr15m revenue, or US$1.4m). Market cap is less than US$100m (€27.6m market cap, or US$30.3m).
お知らせ • Oct 03Opticept Technologies AB (publ) Announces Chief Financial Officer ChangesOptiCept Technologies AB (publ) announced that OptiCept's Chief Financial Officer, Despina Georgiadou Hedin, has decided to step down from her role. Henrik Nettersand will be the new CFO. Despina Georgiadou Hedin, who has been CFO at OptiCept Technologies since 2023, will leave her position no later than April 2, 2025. Henrik Nettersand, currently CFO at S:t Eriks AB, will succeed her. Henrik Nettersand most recently served as CFO at S:t Eriks AB and will assume his new role no later than April 2, 2025. Previously, he was CFO at Besikta Bilprovning for five years and held several leadership roles during his eleven years at John Bean Technologies AB, including as Head of Finance. He began his career as an auditor at KPMG and holds a Master of Science in Economics and Business Administration from Lund University, with a specialization in finance. Henrik has many years of experience in financial leadership roles, both at the company and group levels, and has extensive global experience. His long experience working with multinational companies in growth, both inside and outside Sweden, and with companies delivering complex food technology globally, has given him the expertise and business focus the company need in its global expansion.
New Risk • Sep 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr67m). Revenue is less than US$5m (kr15m revenue, or US$1.4m). Market cap is less than US$100m (€23.2m market cap, or US$25.8m).
Reported Earnings • Aug 30Second quarter 2024 earnings released: kr0.23 loss per share (vs kr0.57 loss in 2Q 2023)Second quarter 2024 results: kr0.23 loss per share (improved from kr0.57 loss in 2Q 2023). Net loss: kr10.3m (loss narrowed 39% from 2Q 2023). Revenue is forecast to grow 48% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Machinery industry in Germany. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has fallen by 58% per year, which means it is significantly lagging earnings.
Buy Or Sell Opportunity • Jul 17Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 153% to €0.59. The fair value is estimated to be €0.48, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 1,205% in 2 years. Earnings are forecast to grow by 81% in the next 2 years.
お知らせ • Jul 02OptiCept Technologies AB Submits Patent Application and Strengthens Its IP-Portfolio for Vacuum Impregnation Focused on CuttingsOptiCept Technologies AB announced that the company has submitted a patent application to the Swedish Patent and Registration Office (PRV). The patent application includes strengthened and expanded patent protection for the company's vacuum impregnation technology, OptiBoost. OptiCept brings the vacuum infusion platform to the next level by specifying the successful treatment conditions for its plant technology platform, OptiBoost. The patent application encompasses the detailed method of treating the plant material such as cuttings leading to improved rooting. Successes with tests on cuttings have prompted the submission of the patent application. The company learns and develops with every new test. The method that OptiCept uses is mastered, and the knowledge of how to control and implement it is becoming stronger and stronger with new activities and a growing portfolio of tested species.The patent application expounds the exact conditions for applying the vacuum infusion process to achieve the most optimal treatment for plants. The treatment must be mild and well-controlled to minimize the stress applied to the plant tissue, which is ensured by the innovative way of designing the vacuum curve. The patent also describes the correct treatment criteria by controlling the percentage of air removed from the tissue and percentage of liquid incorporated into the tissue by specifying the surface impregnation parameters.
Buy Or Sell Opportunity • Jul 01Now 3.4% overvalued after recent price riseOver the last 90 days, the stock has risen 83% to €0.46. The fair value is estimated to be €0.44, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 1,205% in 2 years. Earnings are forecast to grow by 81% in the next 2 years.
Buy Or Sell Opportunity • Jun 25Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 95% to €0.50. The fair value is estimated to be €0.41, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has declined by 13%. Revenue is forecast to grow by 1,205% in 2 years. Earnings are forecast to grow by 81% in the next 2 years.
Breakeven Date Change • Jun 05Forecast to breakeven in 2026The 2 analysts covering OptiCept Technologies expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 60% per year to 2025. The company is expected to make a profit of kr6.00m in 2026. Average annual earnings growth of 82% is required to achieve expected profit on schedule.
Reported Earnings • Jun 04First quarter 2024 earnings released: kr0.35 loss per share (vs kr0.71 loss in 1Q 2023)First quarter 2024 results: kr0.35 loss per share (improved from kr0.71 loss in 1Q 2023). Net loss: kr14.7m (loss narrowed 30% from 1Q 2023). Revenue is forecast to grow 44% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Machinery industry in Germany. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has fallen by 58% per year, which means it is performing significantly worse than earnings.
Board Change • May 30Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Anders Hattmark was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
お知らせ • Apr 12OptiCept Technologies AB Files Patent Application for Combined PEF and VI Treatment of Fruit and Vegetable ProductsOptiCept Technologies AB announced that the company has submitted a new patent application to the Swedish Intellectual Property Office (PRV). The patent application includes a new application area for the company's technologyplatforms CEPT (Controlled Environment PEF treatment) and VI (Vacuum infusion) in fruit and vegetable processing. Success with tests on pineapple chunks has prompted the filing of the patent application. OptiCept has developed a new application area for the company's technology platforms. The patent application includes a Pulsed Electric Field (PEF) step followed by a vacuum injection step, or the steps separately for softening fruit or vegetable products (pieces of fruit or vegetables), where the fruit or vegetable products are impregnated with fruit or vegetable juice to improve product color and texture. This new technology can naturally improve the organoleptic properties of products to be even more appreciated by consumers due to improved texture, consistency, and color. It also creates the conditions to produce completely new products. Success with tests on pineapple chunks has prompted the filing of the patent application.
Reported Earnings • Feb 28Full year 2023 earnings released: kr2.48 loss per share (vs kr5.03 loss in FY 2022)Full year 2023 results: kr2.48 loss per share (improved from kr5.03 loss in FY 2022). Net loss: kr80.4m (loss narrowed 20% from FY 2022). Revenue is forecast to grow 41% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the Machinery industry in Germany.
お知らせ • Feb 27OptiCept Technologies AB (publ), Annual General Meeting, May 24, 2024OptiCept Technologies AB (publ), Annual General Meeting, May 24, 2024.
お知らせ • Dec 22OptiCept Technologies AB (publ) Receives First Partial Results from the Pilot Project to Improve the Staining of Cuttings in ChinaOptiCept Technologies AB (publ) announced that it has received the first partial results from the pilot project to improve the rooting of cuttings in China, which initially focuses on Acacia. The root of Acacia cuttings improved by 12-33% depending on the type of Acacia treated. In May 2023, OptiCept Technologies entered an agreement with Guangxi Shichen Group ("GSG"), in collaboration with the Chinese state research institute Guangxi Academy of Forestry, to evaluate the OptiBoost technology on several different types of cuttings to improve its rooting. Acacia cuttings treated with the patented vacuum impregnation technology show an average improved rooting of 12-33% after 45 days, with the final assessment made after 90 days. Results from the evaluation of Camelia will be available in 2024 when tests for Eucalyptus also will be carried out. Acacia is a large genus with many species. Cultivation of Acacia is particularly common in China, Southeast Asia, South America, Africa, and in Australia, where Acacia forest is the second most common forest type after Eucalyptus forest. Acacia is one of the most cultivated trees in the southern hemisphere and is a fast-growing species that can grow in harsh conditions that other species cannot, which can quickly generate yields.
Reported Earnings • Nov 30Third quarter 2023 earnings released: kr0.67 loss per share (vs kr1.09 loss in 3Q 2022)Third quarter 2023 results: kr0.67 loss per share (improved from kr1.09 loss in 3Q 2022). Net loss: kr20.7m (loss narrowed 4.4% from 3Q 2022). Revenue is forecast to grow 85% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Machinery industry in Germany.
お知らせ • Nov 30+ 2 more updatesOptiCept Technologies AB (publ) to Report Fiscal Year 2023 Results on Feb 27, 2024OptiCept Technologies AB (publ) announced that they will report fiscal year 2023 results on Feb 27, 2024
New Risk • Oct 24New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €9.39m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (19% average weekly change). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Revenue is less than US$1m (kr10m revenue, or US$925k). Market cap is less than US$10m (€9.39m market cap, or US$9.95m). Minor Risks Less than 1 year of cash runway based on current free cash flow (-kr104m). Currently unprofitable and not forecast to become profitable over next 2 years (kr14m net loss in 2 years).
お知らせ • Oct 22OptiCept Technologies AB (publ) Announces CFO ChangesOptiCept Technologies AB (publ) recruited Déspina Georgiadou Hedin as the company's new CFO. Déspina most recently comes from Ascelia Pharma AB (publ), where she held the position of CFO. She will take up her position no later than 1 November 2023. Déspina Georgiadou Hedin now replaces Tomas Andersson, who acted as interim CFO since April 2023 while a permanent recruitment was carried out. She has extensive experience in leading positions in finance and the role of CFO for both listed and unlisted companies. Most recently, she was the CFO at Ascelia Pharma AB and before that, she was, among other things, CFO and HR manager at Bioglan AB, as well as Chief Accountant and Senior Financial Specialist at Sol Voltaics AB. Déspina has a bachelor's degree in economics from Linnaeus University, Växjö/Kalmar.
Reported Earnings • Aug 30Second quarter 2023 earnings released: kr0.57 loss per share (vs kr1.10 loss in 2Q 2022)Second quarter 2023 results: kr0.57 loss per share (improved from kr1.10 loss in 2Q 2022). Net loss: kr17.1m (loss narrowed 22% from 2Q 2022). Revenue is forecast to grow 71% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Machinery industry in Germany.
お知らせ • Feb 07OptiCept Technologies AB (publ), Annual General Meeting, Mar 08, 2023OptiCept Technologies AB (publ), Annual General Meeting, Mar 08, 2023.
Breakeven Date Change • Nov 16Forecast breakeven date pushed back to 2024The analyst covering OptiCept Technologies previously expected the company to break even in 2022. New forecast suggests losses will reduce by 35% per year to 2023. The company is expected to make a profit of kr2.00m in 2024. Average annual earnings growth of 87% is required to achieve expected profit on schedule.
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). Director Elisabeth Yllfors was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Breakeven Date Change • Nov 08Forecast breakeven date pushed back to 2024The analyst covering OptiCept Technologies previously expected the company to break even in 2022. New forecast suggests losses will reduce by 35% per year to 2023. The company is expected to make a profit of kr2.00m in 2024. Average annual earnings growth of 87% is required to achieve expected profit on schedule.
お知らせ • Oct 01Thomas Lundqvist acquired additional minority stakes in OptiCept Technologies AB (publ) (OM:OPTI).Thomas Lundqvist acquired additional minority stakes in OptiCept Technologies AB (publ) (OM:OPTI) on September 29, 2022. Thomas Lundqvist ill acquire 5300 shares at a price of SEK 28.28. Thomas Lundqvist completed the acquisition of additional minority stakes in OptiCept Technologies AB (publ) (OM:OPTI) on September 29, 2022.
お知らせ • May 17Opticept Technologies AB (publ) Announces CEO ChangesOptiCept Technologies' CEO Johan Möllerström has chosen to resign as CEO from the Annual General Meeting on May 25, 2022. The new CEO will be Thomas Lundqvist, who is currently part of the management team as Head of Sales. Johan Möllerström has been CEO of ArcAroma and now OptiCept for 5.5 years and over the years has changed the companies' focus from biogas to food, from freezing processes to cut flowers, and from innovation to commercial success.
Reported Earnings • May 09First quarter 2022 earnings released: kr0.74 loss per share (vs kr0.47 loss in 1Q 2021)First quarter 2022 results: kr0.74 loss per share (down from kr0.47 loss in 1Q 2021). Net loss: kr14.8m (loss widened 162% from 1Q 2021). Over the next year, revenue is forecast to grow 4,589%, compared to a 8.9% growth forecast for the industry in Germany.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (5 non-independent directors). Director Elisabeth Yllfors was the last director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Apr 02+ 3 more updatesOptiCept Technologies AB (publ), Annual General Meeting, May 25, 2022OptiCept Technologies AB (publ), Annual General Meeting, May 25, 2022.
Reported Earnings • Feb 10Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: kr2.61 loss per share (down from kr1.23 loss in FY 2020). Net loss: kr42.5m (loss widened 199% from FY 2020). Revenue missed analyst estimates by 38%. Over the next year, revenue is forecast to grow 2,568%, compared to a 10% growth forecast for the industry in Germany.
Breakeven Date Change • Sep 23Forecast to breakeven in 2021The analyst covering OptiCept Technologies expects the company to break even for the first time. New forecast suggests the company will make a profit of kr40.0m in 2021. Earnings growth of 89% is required to achieve expected profit on schedule.
Reported Earnings • Feb 18Full year 2020 earnings released: kr1.03 loss per share (vs kr0.81 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: kr3.33m (down 40% from FY 2019). Net loss: kr11.9m (loss widened 43% from FY 2019).
お知らせ • Feb 18OptiFreeze AB (publ) (NGM:OPTI) agreed to acquire ArcAroma AB (publ) (OM:AAA).OptiFreeze AB (publ) (NGM:OPTI) agreed to acquire ArcAroma AB (publ) (OM:AAA) on February 16, 2021. The transaction is subject to shareholders approval of ArcAroma AB (publ). The transaction is approved by the Board of ArcAroma AB (publ).
